Chorea Market Research Report - Global Forecast till 2027

Chorea Market Research Information: by Type (Huntington’s disease, Sydenham’s chorea, Drug-induced chorea), Treatment (Medical Care, Surgical Care), Distribution Channel (Hospitals, Diagnostic Centers, Drug Stores, Pharmacies) – forecast till 2027

ID: MRFR/HC/3782-HCR | | Region: Global | 85 Pages         

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Chorea Market, by Type

6.1 Introduction

6.2 Huntington’s Disease

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Rheumatic (Sydenham’s chorea)

6.3.1 Market Estimates & Forecast, 2020 – 2027

6.4 Drug-Induced Chorea

6.4.1 Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Chorea Market, by Treatment

7.1 Introduction

7.2 Medical Care

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Surgical Care

7.3.1 Market Estimates & Forecast, 2020-2027

Chapter 8. Global Chorea Market, by Distribution Channel

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Clinics

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Diagnostic Centers

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Drug Stores

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Pharmacies

8.6.1 Market Estimates & Forecast, 2020-2027

8.7 Others

8.7.1 Market Estimates & Forecast, 2020-2027

Chapter 9. Global Chorea Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Teva Pharmaceutical Industries Ltd.

11.1.1 Company Overview

11.1.2 Type of Causative Agents Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Valeant

11.2.1 Company Overview

11.2.2 Type of Causative Agents Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Medtronic

11.3.1 Company Overview

11.3.2 Type of Causative Agents Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Alnylam Pharmaceuticals, Inc.

11.4.1 Company Overview

11.4.2 Type of Causative Agents/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Cyberonics, Inc.

11.5.1 Company Overview

11.5.2 Type of Causative Agents Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 AmpliPhi Biosciences Corp

11.6.1 Company Overview

11.6.2 Type of Causative Agents Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 CEREGENE INC.

11.7.1 Overview

11.7.2 Type of Causative Agents Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Chorea Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Chorea Industry Synopsis, 2020-2027

Table 2 Chorea Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Chorea Market by Region, 2020-2027, (USD Million)

Table 4 Chorea Market by Type, 2020-2027, (USD Million)

Table 5 Chorea Market by Treatment, 2020-2027, (USD Million)

Table 6 Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 7 North America Chorea Market by Type, 2020-2027, (USD Million)

Table 8 North America Chorea Market by Treatment, 2020-2027, (USD Million)

Table 9 North America Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 10 US Chorea Market by Type, 2020-2027, (USD Million)

Table 11 US Chorea Market by Treatment, 2020-2027, (USD Million)

Table 12 US Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 13 Canada Chorea market by Type, 2020-2027, (USD Million)

Table 14 Canada Chorea Market by Treatment, 2020-2027, (USD Million)

Table 15 Canada Chorea market by Distribution Channels, 2020-2027, (USD Million)

Table 16 South America Chorea Market by Type, 2020-2027, (USD Million)

Table 17 South America Chorea Market by Treatment, 2020-2027, (USD Million)

Table 18 South America Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 19 Europe Chorea Market by Type, 2020-2027, (USD Million)

Table 20 Europe Chorea Market by Treatment, 2020-2027, (USD Million)

Table 21 Europe Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 22 Western Europe Chorea Market by Type, 2020-2027, (USD Million)

Table 23 Western Europe Chorea Market by Treatment, 2020-2027, (USD Million)

Table 24 Western Europe Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 25 Eastern Europe Chorea market by Type, 2020-2027, (USD Million)

Table 26 Eastern Europe Chorea Market by Treatment, 2020-2027, (USD Million)

Table 27 Eastern Europe Chorea Market by Distribution Channels, 2020-2027, (USD Million)

Table 28 Asia Pacific Chorea Market by Type, 2020-2027, (USD Million)

Table 29 Asia Pacific Chorea Market by Treatment, 2020-2027, (USD Million)

Table 30 Asia Pacific Chorea market by Distribution Channels, 2020-2027, (USD Million)

Table 31 Middle East & Africa Chorea Market by Type, 2020-2027, (USD Million)

Table 32 Middle East & Africa Chorea Market by Treatment, 2020-2027, (USD Million)

Table 33 Middle East & Africa Chorea market by Distribution Channels, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Chorea Market

Figure 3 Segmentation Market Dynamics for Chorea Market

Figure 4 Global Chorea market Share, by Type 2027

Figure 5 Global Chorea market Share, by Treatment 2027

Figure 6 Global Chorea market Share, by Distribution Channels, 2027

Figure 7 Global Chorea market Share, by Region, 2027

Figure 8 North America Chorea market Share, by Country, 2027

Figure 9 Europe Chorea market Share, by Country, 2027

Figure 10 Asia Pacific Chorea market Share, by Country, 2027

Figure 11 Middle East & Africa Chorea market Share, by Country, 2027

Figure 12 Global Chorea market: Company Share Analysis, 2027 (%)

Figure 13 Teva Pharmaceutical Industries Ltd.: Key Financials

Figure 14 Teva Pharmaceutical Industries Ltd. Segmental Revenue

Figure 15 Teva Pharmaceutical Industries Ltd.: Geographical Revenue

Figure 16 Valeant: Key Financials

Figure 17 Valeant: Segmental Revenue

Figure 18 Valeant: Geographical Revenue

Figure 19 Medtronic: Key Financials

Figure 20 Medtronic: Segmental Revenue

Figure 21 Medtronic: Geographical Revenue

Figure 22 Alnylam Pharmaceuticals, Inc.: Key Financials

Figure 23 Alnylam Pharmaceuticals, Inc.: Segmental Revenue

Figure 24 Alnylam Pharmaceuticals, Inc.: Geographical Revenue

Figure 25 Cyberonics, Inc.: Key Financials

Figure 26 Cyberonics, Inc.: Segmental Revenue

Figure 27 Cyberonics, Inc. Geographical Revenue

Figure 28 AmpliPhi Biosciences Corp: Key Financials

Figure 29 AmpliPhi Biosciences Corp: Segmental Revenue

Figure 30 AmpliPhi Biosciences Corp: Geographical Revenue

Figure 31 CEREGENE INC.: Key Financials

Figure 32 CEREGENE INC.: Segmental Revenue

Figure 33 CEREGENE INC.: Geographical Revenue

Chorea Market Speak to Analyst Request a Free Sample

Chorea Market Overview


Chorea market is projected to grow at a CAGR 11.4% during the forecast period. Chorea is otherwise known as motion disorder, which gives unpredictable, involuntary and irregular muscle movements. The growing awareness regarding its symptoms among the population is predicted to enhance the treatment of market and its growth rate. This is a disorder that can make a person look restless or fidgety. The rising initiative's activities by major healthcare organizations and governments are predicted to support the growth of the market in the forecast period. The growing concern and awareness regarding various muscles disorder provide the treatment for market a profitable growth. The rising commonness of Huntington's disease leads to a rise in the patient pool suffering from the chorea disorder; as a result, the demand for chorea treatment is predicted to rise. The chorea market gives details of market share, new development and product pipeline analysis, the impact of domestic and local market players, changes in market regulation, analyzing opportunities in terms of emerging revenue pockets, product approvals, product launch, strategic decision, technological innovations and expansion in the market.  


Covid-19 analysis


The sudden outbreak of the Nobel virus Covid-19 led to the implementation of lockdowns and shutdowns by governments worldwide, which directly affected the chorea market by breakage in import and export activities of the market. COVID-19 can affect the global economy in three main ways: by directly hampering production and demand, creating breakage in supply chain and market, and impacting firms and financial markets financially. The analysts monitor the global situation and explain that the market will generate profitable prospects for the producers post COVID-19 crisis. 


Chief Factors Existing In The Market 



  • Key Market Drivers


The involvement of major market players is predicted to provide higher market growth for a cure for the chorea treatment market. The population of patients is growing high in numbers and the quality of spreading diseases widely across the world. Increasing demand for advanced products, such as gene therapy and stem cell therapy, is responsible for the market growth and enhances the chorea market value. The increase in chorea disease commonness is considered to be the major driving force for market size growth in the coming years. 



  • Market Challenges


This disease is exceptionally rare, so more data and knowledge are required to cure this dangerous disease. As there is a lack of knowledge, there is a lack of awareness about how this disease is being treated. 



  • Market opportunities


The increasing use of chorea treatment in hospitals, clinics and other industries is driving the growth of the Chorea Treatment market across the globe, and it can be the greatest opportunity that provides scope to the chorea market to grow. More number of hospitals and clinics means more contribution to the economy, which is a perk for the market.



  • Market Restraints


The lack of skilled persons in manufacturing effective drugs is slightly hampering the chorea market's growth. The sudden and rapid changes in the economic strategies negatively impact the development of the chorea market share. The most challenging thing for the market development is the alternative method which is available at a lower cost. Less knowledge about generic erosion is also a factor that hampers the demand of the market.


Cumulative Evaluation Of The Market 


Chorea is an abnormal involuntary movement categorized by brief, unpredictable, abrupt, irregular, non-stereotyped movements. Chorea may worsen with anxiety and subsides during sleep and voluntary movements. The major causes of Chorea include the use of pregnancy, oral contraceptives, autoimmune disorders, paraneoplastic syndromes, hyperglycemia, hyperthyroidism, and hypoparathyroidism. In 2016 according to the Neurodegenerative Disease Management journal, the commonness of Chorea was lower in Asian populations as compared to Western Europe, Australia, and North America.


Market Segmentation


The global chorea market is divided on the basis of type, treatment, and distribution channels.


Under this type, the chorea market is classified as Huntington's disease, Rheumatic (Sydenham's Chorea), and Drug-induced Chorea.


Under the basis of the treatment, the market is classified as medical care and surgical care. The medical care is further divided into neuroleptics, dopamine-depleting agents, GABAergic drugs, coenzyme Q10, intravenous immunoglobulin, and plasmapheresis. The sub-divisions neuroleptic includes typical neuroleptics and atypical neuroleptics. The surgical care is further divided into deep brain stimulation and cell transplantation.


Under the basis of the distribution channel, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others. This gives a short representation of the Chorea Market outlook.


Under the basis of symptoms, the chorea treatment market is segmented into involuntary muscle movements, milkmaid's grip, speech problems, and seizures.


Under the basis of end-users, the chorea treatment market is segmented into clinics, hospitals, ambulatory surgical centers and others.


Regional Analysis


The chorea market forecast is dominated by America owing to the increasing awareness among the population and high healthcare expenditure. In 2015 according to the Centers for Disease Control and Prevention, the total health expenditure in the U.S. was reported to be USD 3.2 trillion, and hospital care was considered for a share of 32.3%.


Europe has the second rank in the chorea market. It is expected that the support provided by the government bodies for research & development and improvement in the repaying policies in healthcare is likely to operate the market of the Europe region.


The Asia Pacific is the fastest growing chorea market owing to developing healthcare technology and a huge patient pool. Healthcare expenditure is also improving in various countries of Asia Pacific. In the years 2015-2016, according to the Australian Institute of Health and Welfare, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015.


The Middle East & Africa has the lowest market due to poor medical provisions and lack of technical knowledge.


Competitive Intensity Within The Industry


According to Chorea market analysis, it has a competitive landscape that provides details by a competitor. The details that included are company financials, company overview, revenue generated, market potential, new market initiatives, investment in research and development, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above information is only related to the companies' focus on the chorea treatment market.


The major players covered in the chorea treatment market are Medtronic plc., Boston Scientific Corporation, ALEVA NEUROTHERAPEUTICS SA, Pfizer Inc., GlaxoSmithKline plc., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., LivaNova, PLC, H. Lundbeck A/S, Ipsen, Alnylam Pharmaceuticals Inc., RespireRx Pharmaceuticals Inc., Vertex Pharmaceuticals, Inc., Prana Biotechnology Ltd., and SOM Innovation Biotech, S.A. among other domestic and global players. 


Recent Market Developments 



  • Spark Therapeutics, Inc. formed a partnership with NeuExcell Therapeutics Inc to develop gene therapy for treating chorea patients.

  • China's national medical products association has approved Austedo, a drug expected to treat Chorea in association with H.D. by Teva pharmaceutical industries LTD. The company is expanding its patient base and revenue by geographical expansion.

  • The company Voyager Therapeutics, the gene therapy company, has now appointed AI Sandrock, the reputed researcher who spent almost half of his career overseeing the clinical development activities at Biogen as CEO.


Report Overview 


This report includes the market overview, covid-19 analysis and how it affects the market, the key drivers, the market opportunities, the key drivers, the challenges that the market face, the market restraints, the market segmentation, the regional analysis, chorea market trends, the competitive landscape, report overview and recent development of the market.


Key Industrial Segments 


On the basis of product type



  • Medication 

  • Surgery therapy


On the basis of the end-user application



  • Hospitals 

  • Clinics

  • Others


On the basis of treatment 



  • Medical care

  • Surgical care


On the basis of end-user or application



  • Clinics 

  • Hospitals

  • Ambulatory surgical centers 

  • Others.


On the basis of regions



  • North America

  • Europe 

  • Asia Pacific

  • South America

  • The Middle East and Africa



Speak to Analyst Ask for Customization